COVID-19 Webinar: Mitigating the Intersection of COVID-19 and Opioid Use Disorder

Keeping patients with opioid use disorder engaged in treatment in a rapidly altered practice dynamic due to COVID19 is critical. This discussion and interactive panel with clinicians, policy experts, and regulators will highlight the challenges faced in addressing the complex issues involved in such efforts. Emergency changes in regulations to lower barriers to care such as buprenorphine prescribing by telehealth and revised methadone dispensing can foster a more patient-centered approach and access to recovery care. But is it safe, what are the outcomes, and should it be continued?